stars 1 stars 2 stars 3

Cellaviva is Scandinavia’s leading private biobank specializing in family stem cell preservation from the afterbirth, including umbilical cord blood, cord tissue and placenta. With full regulatory approval from the Swedish Health and Social Care Inspectorate (IVO), Cellaviva is the only biobank of its kind in Sweden. Our services are grounded in the latest scientific standards and aim to provide families with long-term health security through access to future medical treatments. In addition to stem cell banking, Cellaviva offers a growing portfolio of genetic tests and preventive health services designed to support proactive healthcare and early intervention. We work in close collaboration with healthcare providers, public authorities, and research institutions to ensure quality, safety, and ethical excellence in everything we do.

Cellaviva Questions

The Cellaviva annual revenue was $6 million in 2026.

Sofie Jansson is the Chief Executive Officer (CEO) of Cellaviva.

5 people are employed at Cellaviva.

The NAICS codes for Cellaviva are [32, 3254, 325].

The SIC codes for Cellaviva are [28, 80, 283].

Top Cellaviva Employees

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users